表紙
市場調查報告書
商品編碼
660994

臨床試驗管理系統(CTMS)的全球市場:各傳送模式,零組件,終端用戶,系統,及地理的成長率,趨勢及預測(2018年∼2023年)

Clinical Trial Management Systems Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

出版日期: | 出版商: Mordor Intelligence Pvt Ltd | 英文 118 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

全球臨床試驗管理系統(CTMS)市場,預計從2018年到2023年的預測期間內,以12.5%的年複合成長率成長。臨床試驗管理系統,主要是製藥公司和生物科技企業實施的醫療研究中為了管理大量的臨床資料的軟體解決方案。由於有利的政府政策與各種政府的財政援助機關的支援,預計北美在預測期間內主導市場。

本報告提供全球臨床試驗管理系統市場調查,整體市場趨勢,各產品、地區的詳細趨勢,市場成長的影響要素分析,競爭情形,主要企業簡介等,總括性彙整。

目錄

第1章 簡介

  • 市場定義

第2章 調查方法

第3章 摘要整理

第4章 主要推論

第5章 市場概要

  • 目前市場方案
  • 波特的五力分析
    • 供應商談判力
    • 消費者談判力
    • 新加入廠商的威脅
    • 替代產品及服務的威脅
    • 產業內的競爭

第6章 成長要素,阻礙因素,機會,課題分析(DROC)

  • 成長要素
    • 慢性疾病和文明病的發生率的上升
    • 臨床試驗的外包的增加與受託研究機構(CRO)的實施
    • 醫院資訊系統(HIS)和CTMS的協調
  • 阻礙因素
    • 資料安全的問題
    • CTMS相關的高成本
    • 為了處理CTMS的有資格的技術純熟勞工的不足
  • 市場機會
  • 主要課題

第7章 市場區隔

  • 各傳送模式
    • Web為基礎
    • 內部部署
    • 雲端基礎
  • 各零件
    • 軟體
    • 硬體設備
    • 服務
  • 終端用戶
    • 醫藥品
    • 臨床研究機關
    • 醫療保健供應商
  • 系統的各類型
    • 網站為基礎的臨床試驗管理系統
    • 接受授權的企業為基礎的臨床試驗管理系統
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲
    • 南美

第8章 競爭情形

  • M&A分析
  • 協定,合作,夥伴關係
  • 新產品的銷售

第9章 主要業者

  • Bioclinica
  • Bio-Optronics, Inc.
  • DATATRAK International, Inc.
  • ERT Clinical
  • IBM Watson Health
  • Medidata Solutions, Inc.
  • MedNet Solutions, Inc.
  • Oracle Corporation
  • Parexel International Corporation
  • Sparta Systems, Inc. 等

第10章 市場未來展望

目錄
Product Code: 49652

The Clinical Trial Management Systems market is expected to registering a CAGR of 8.5% during the forecast period.

Amid the COVID-19 pandemic, the health system of countries are rapidly investing in research and development to combat the virus. Potential compounds were screened from the CHEMBL database, ZINC database, FDA-approved drugs, and molecules under clinical trials. Therefore, it is expected that COVID-19 will have a positive impact on the market growth over the forecast period. In April 2020, Cytel Inc. has launched an open-access global COVID-19 Clinical Trial Tracker that will facilitate huge collaboration between researchers, policymakers, clinicians, journalists, philanthropists, and other critical stakeholders.

The growing number of clinical trials due to rising chronic diseases and lifestyle-related disorders and the increase in outsourcing of clinical trials and implementation by contract research organizations are the factors that are driving the market growth.

According to the Global Alliance for Chronic Diseases (GACD) 2018, one in ten individuals are predicted to have type 2 diabetes by 2035 worldwide and is predicted to be the 7th leading cause of death by 2030. Additionally, as per the World Health Organization 2020, the major chronic diseases such as cardiovascular diseases (CVD), cancer, chronic obstructive pulmonary disease and type 2 diabetes are estimated to account to 73% of all deaths and 60% of the global burden of diseases in 2020.

The burden of chronic diseases is increasing the number the clinical trials which is increasing adoption of clinical trial management systems driving market growth. Additionally, pharmaceutical and biopharmaceutical are heavily investing in research and development. For instance, in 2019, Xtalpi, an American Chinese based biotech company has raised a USD 319 million funding for the advancement in its Intelligent Digital Drug Discovery and Development (ID4) platform that provides prediction of small molecules candidates properties, solid-form selection, and other services.

The high investment in clinical trial in last few years has boosted the market for clinical trial management systems. Many companies that have developed clinical trial management systems have found a way to integrate with the existing software providers, in order to provide an efficient workflow in clinical trial management.

Moreover, increasing innovative technological advancements to curb the increasing costs associated with clinical trials have resulted in the development of the clinical trial management system. Although these systems have not been completely adapted due to various factors, the increasing awareness and the need to cut down additional costs associated with clinical trials are expected to drive the market in the future. However, data security isssues and high cost associated with clinical trial management systems are the factors that are anticipated to restrain market growth.

Key Market Trends

Pharmaceutical Segment is Expected to Exhibit Fastest Growth Rate over the Forecast Period

By End User, Pharmaceuticals is expected to hold a significant market share during the forecast period as pharmaceutical companies are rapidly adopting clinical trial management systems to manage clinical trials, as part of their pharmaceutical and biotechnology research activities. This software is used by researchers to define, implement, and track the results of clinical trials. Administrative personnel of clinical trials also use this type of application to find and schedule participants and track their involvement in the trials.

Also, pharmaceutical and biopharmaceutical companies have one of the highest Research and Development expenses worldwide. This is the major factor that encourages various pharma companies to opt for software solutions including clinical trial management solutions to manage the large volume of data, thereby augmenting the market expansion.

The use of this comprehensive software and services has increased among pharmaceutical industries, due to increased funding over the years. UCB, a Belgian multinational company boosted its Research and Development spending increased by 23% in 2020 to EUR 1.569 billion. This translates to more spending on clinical trials and its management. This has helped the market growth in recent years. Moreover, with the continuing trend, it is expected to boost the market studied, during the forecast period.

North America Captured the Largest Market Share and is Expected to Retain its Dominance

North America dominated the overall clinical trial management systems market, with the United States emerging as the major contributor to the market. Factors, such as increasing research and development investments and a rise in the demand for drug development, are aiding the growth of the market studied in the country. According to ClinicalTrials.gov, 2020 currently lists 358,156 studies with locations in all 50 States and in 218 countries as compared to 2018 that was around 285,679 clinical trials being performed. The increasing number of studies and clinical trials, coupled with the increased funding for clinical research, is likely to drive business growth

R&D budgets of pharmaceutical companies have also increased in the last few years, owing to the increasing focus on regulating markets, complex molecules, and therapy segments. In the United States, pharmaceutical companies spend more money, time, and energy on R&D than others. For instance, as per Pharmaceutical Research and Manufacturers of America, the biopharmaceutical industry invested an estimated USD 102 billion in research and development (R&D) in 2018.

Therefore, the rise in research and clinical trials in the region is expected to increase the demand for clinical trial management systems, which, in turn is expected to aid the growth of the market studied in the region over the forecast period.

Competitive Landscape

The presence of major market players, such as Bio-Optronics Inc., MedNet Solutions Inc., Oracle Corporation, Calyx, and IBM, is increasing the overall competitive rivalry of the market studied.

Large organizations rely heavily on advertising expenses and branding strategies, collaborations, initiatives, or programs at national levels, which promote their product, and thus, get recognized earlier than other brands in the market. With the high prevalence rate of diseases, the intensity of competitive rivalry in the market studied is expected to increase, during the forecast period.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Number of Clinical Trials Due to Rising Chronic Diseases and Lifestyle-related Disorders
    • 4.2.2 Rise in Outsourcing of Clinical Trials and Implementation by Contract Research Organizations
  • 4.3 Market Restraints
    • 4.3.1 Data Security Issues
    • 4.3.2 High Cost Associated With Clinical Trial Management Systems
  • 4.4 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Delivery Mode
    • 5.1.1 On-premise
    • 5.1.2 Cloud-based
  • 5.2 By Component
    • 5.2.1 Software
    • 5.2.2 Services
  • 5.3 By End User
    • 5.3.1 Pharmaceuticals
    • 5.3.2 Contract Research Organization
    • 5.3.3 Other End Users
  • 5.4 By Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 United Kingdom
      • 5.4.2.2 Germany
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 ArisGlobal LLC
    • 6.1.2 Bioclinica
    • 6.1.3 Bio-Optronics Inc.
    • 6.1.4 DATATRAK International Inc.
    • 6.1.5 DZS Clinical Services
    • 6.1.6 ERT Clinical
    • 6.1.7 IBM
    • 6.1.8 Dassault Systemes (Medidata Solutions Inc.)
    • 6.1.9 MedNet Solutions Inc.
    • 6.1.10 Oracle Corporation
    • 6.1.11 Calyx
    • 6.1.12 RealTime Software Solutions LLC
    • 6.1.13 Veeva Systems

7 MARKET OPPORTUNITIES AND FUTURE TRENDS